ALPHA TRIBE

Relaxo Footwears LimitedInvestor Meet, 03-06-2026: Analysts/Institutional Investor Meet/Con. Call Updates

03-06-2026 | 01:08 pm

Relaxo Footwears posted strong Q4 FY26: Revenue up 8.1% YoY to ₹751 Cr, EBITDA 10.6% up to ₹124 Cr (16.5% margin), PAT surged 20.4% to ₹68 Cr (9.0% margin). FY26 revenue was ₹2,702 Cr.

Growth in Q4 was driven by strong volumes and general trade recovery. The company enacted 15-18% price hikes to counter 12-15% cost increases (wages, raw materials), aiming for margin protection. Plans include 100 new EBOs (capex ₹180-200 Cr) and premium product expansion (Sparx up to ₹2,800). Targeting 4-5% volume growth. Management expresses cautious optimism for FY27, eyeing 1% operating margin improvement.

No comments yet. Be the first to comment!

All announcements from Relaxo Footwears Limited